FTB Advisors »

Trevi Therapeutics shares owned by FTB Advisors

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by FTB Advisors from 13F filings

Historical chart of FTB Advisors investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by FTB Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by FTB Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $2.7k 500 5.47

More positions owned by FTB Advisors

Spdr S&p500 Etf Trust Trust Unit Depositary Receipt Common Stock (SPY)
Ishares Core S&p 500 Etf Common Stock (IVV)
Microsoft Corp Common Stock (MSFT)
Jpmorgan Chase &co Common Stock (JPM)
Broadcom Common Stock (AVGO)
Apple Common Stock (AAPL)
Ishares Core S&p Mid-cap Etf Common Stock (IJH)
Cisco Systems Common Stock (CSCO)
International Bus Mach Corp Com Usd0.20 Common Stock (IBM)
Ishares Msci Eafe Etf Common Stock (EFA)
Vanguard Index Fds Vanguard Growth Etf Formerly Vanguard Index Tr Vipers Common Stock (VUG)
Home Depot Common Stock (HD)
Ishares Tr Rus 1000 Grw Etf Common Stock (IWF)
Ishares Core Us Aggregate Bond Etf Common Stock (AGG)
Vanguard Intl Equity Index Fds Allwrld Ex Us Common Stock (VEU)

View all positions for FTB Advisors

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Viking Global Investors
Vivo Capital
Marshall Wace
Alliancebernstein
MPM Oncology Impact Management
OrbiMed Advisors
FMR
Wellington Management Company
Octagon Capital Advisors
Affinity Asset Advisors

View all funds holding Trevi Therapeutics